These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 21933447)

  • 1. Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer.
    Xia X; Ma Q; Li X; Ji T; Chen P; Xu H; Li K; Fang Y; Weng D; Weng Y; Liao S; Han Z; Liu R; Zhu T; Wang S; Xu G; Meng L; Zhou J; Ma D
    BMC Cancer; 2011 Sep; 11():399. PubMed ID: 21933447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic p21 is responsible for paclitaxel resistance in ovarian cancer A2780 cells.
    Xia X; Ji T; Liu R; Weng Y; Fang Y; Wang Z; Xu H
    Eur J Gynaecol Oncol; 2015; 36(6):662-6. PubMed ID: 26775347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of mitochondrial Smac release by Akt in chemoresistant ovarian cancer cells].
    Yang XK; Wang JD; Wang SY; Zhang YX
    Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):259-62. PubMed ID: 18788627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tumor suppressor gene PTEN on the resistance to cisplatin in human ovarian cancer cell lines and related mechanisms.
    Wu H; Cao Y; Weng D; Xing H; Song X; Zhou J; Xu G; Lu Y; Wang S; Ma D
    Cancer Lett; 2008 Nov; 271(2):260-71. PubMed ID: 18657898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of LRRC8A protects human ovarian and alveolar carcinoma cells against Cisplatin-induced expression of p53, MDM2, p21Waf1/Cip1, and Caspase-9/-3 activation.
    Sørensen BH; Nielsen D; Thorsteinsdottir UA; Hoffmann EK; Lambert IH
    Am J Physiol Cell Physiol; 2016 Jun; 310(11):C857-73. PubMed ID: 26984736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.
    Mujoo K; Watanabe M; Nakamura J; Khokhar AR; Siddik ZH
    J Cancer Res Clin Oncol; 2003 Dec; 129(12):709-18. PubMed ID: 14513366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HSP27 Knockdown Increases Cytoplasmic p21 and Cisplatin Sensitivity in Ovarian Carcinoma Cells.
    Lu H; Sun C; Zhou T; Zhou B; Guo E; Shan W; Xia M; Li K; Weng D; Meng L; Xu X; Hu J; Ma D; Chen G
    Oncol Res; 2016; 23(3):119-28. PubMed ID: 26931434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloroquine reverses chemoresistance via upregulation of p21
    Hwang JR; Kim WY; Cho YJ; Ryu JY; Choi JJ; Jeong SY; Kim MS; Kim JH; Paik ES; Lee YY; Han HD; Lee JW
    Cell Death Dis; 2020 Dec; 11(12):1034. PubMed ID: 33277461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism.
    Al-Bahlani S; Fraser M; Wong AY; Sayan BS; Bergeron R; Melino G; Tsang BK
    Oncogene; 2011 Oct; 30(41):4219-30. PubMed ID: 21516125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wogonin Increases Cisplatin Sensitivity in Ovarian Cancer Cells Through Inhibition of the Phosphatidylinositol 3-Kinase (PI3K)/Akt Pathway.
    Xing F; Sun C; Luo N; He Y; Chen M; Ding S; Liu C; Feng L; Cheng Z
    Med Sci Monit; 2019 Aug; 25():6007-6014. PubMed ID: 31402794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between the Akt-regulated direct p53 mitochondrial translocation and the resistance to cisplatin of ovarian cancer cells].
    Zhou Y; Wang SY; Yang XK; Wang HM
    Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):97-100. PubMed ID: 21575475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reversal of drug resistance in human ovarian cancer cells by wild-type PTEN gene and its mechanisms].
    Wu HJ; Wu HT; Weng DH; Xing H; Lu YP; Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):612-6. PubMed ID: 17983517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner.
    Yan X; Fraser M; Qiu Q; Tsang BK
    Gynecol Oncol; 2006 Aug; 102(2):348-55. PubMed ID: 16545436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells.
    Fraser M; Leung BM; Yan X; Dan HC; Cheng JQ; Tsang BK
    Cancer Res; 2003 Nov; 63(21):7081-8. PubMed ID: 14612499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer.
    Koster R; di Pietro A; Timmer-Bosscha H; Gibcus JH; van den Berg A; Suurmeijer AJ; Bischoff R; Gietema JA; de Jong S
    J Clin Invest; 2010 Oct; 120(10):3594-605. PubMed ID: 20811155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: involvement in p53 regulation and cisplatin resistance.
    Leung EL; Fraser M; Fiscus RR; Tsang BK
    Br J Cancer; 2008 Jun; 98(11):1803-9. PubMed ID: 18506185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance.
    Ramadoss S; Sen S; Ramachandran I; Roy S; Chaudhuri G; Farias-Eisner R
    Oncogene; 2017 Mar; 36(11):1537-1545. PubMed ID: 27694900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The p21(cip1/waf1) cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cells.
    Lincet H; Poulain L; Remy JS; Deslandes E; Duigou F; Gauduchon P; Staedel C
    Cancer Lett; 2000 Dec; 161(1):17-26. PubMed ID: 11078909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diammine dicarboxylic acid platinum enhances cytotoxicity in platinum-resistant ovarian cancer cells through induction of apoptosis and S-phase cell arrest.
    Zheng H; Hu W; Yu D; Shen DY; Fu S; Kavanagh JJ; Wei IC; Yang DJ
    Pharm Res; 2008 Oct; 25(10):2272-82. PubMed ID: 18509599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel.
    Mitsuuchi Y; Johnson SW; Selvakumaran M; Williams SJ; Hamilton TC; Testa JR
    Cancer Res; 2000 Oct; 60(19):5390-4. PubMed ID: 11034077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.